healthy4u

A Call For Congressional Investigation Of The HIT Industry - Is This Industry Trying to Harm Patients? Part 5 of a Series

(Note: Part 1 of this series is <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-idiots-part-1.html">here</a>, part 2 is <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-testers-and.html">here</a>, part 3 is <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-testers-and_24.html">here</a>, part 4 is <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-testers-and_26.html">here</a>, part 5 is <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-testers-and_27.html">here</a>, part 6 is <a href="http://hcrenewal.blogspot.com/2009/02/it-makes-healthcare-easier-is-this.html">here</a>, part 7 is <a href="http://hcrenewal.blogspot.com/2009/03/information-technology-makes-healthcare.html">here</a>, and part 8 is <a href="http://hcrenewal.blogspot.com/2009/03/malpractices-of-multitudes-mission.html">here</a>. 2011 addendums: a post that can be considered part 9 is <a href="http://hcrenewal.blogspot.com/2011/04/special-k-red-berries-mission-hostile.html">here</a>, part 10 is <a href="http://hcrenewal.blogspot.com/2011/12/ehr-mission-hostile-user-experience.html">here</a>.) In this installment of illustrating defects in today's contemporary health IT, I was going to present more sketches (since contractual clauses between HIT vendors and hospitals tend to forbid sharing of actual screens or defects) of the "let's play peek a boo" variety. I will present them in part 6 instead. These are screens in which clinicians must scroll extensively to, say, match an INR with a coumadin dose, FiO2 with oximetry result, match systolic with diastolic blood pressure, search around nearly empty screens to reveal a single value many rows down, enter a few common diagnoses via the "clickorrhea" of almost fifty clicks, and other patent absurdities from technology touted as "improving medicine." I am using part 5 to present another issue: A call for investigation of the HIT device industry, its development, marketing, talent management, contracting, QC, and information sharing practices on bugs and defects. I have now become aware of organizations with defects/clinician complaint lists for contemporary HIT including CPOE, EHR etc. amounting to well over a hundred pages in one case, and well over a thousand individual items in another, and numerous unquantified but relevant in-betweens. I recently also received this from a correspondent with expertise in user interaction design: <blockquote>A funny story [that is actually not funny at all - ed.] When I managed Operating room systems for a hospital the vendor was [major vendor, name redacted]. The UI was awful. Though the implementation had many problems (prior to my taking the job) circulating nurses were livid. Some actually filed a complaint with the state's department of health claiming the new system endangered patient safety. Alas, the "inspection" ruled it was not endangering patients. [I'm sure the inspectors had significant healthcare IT and informatics domain expertise. Well, no, actually - ed.] One day I was talking to a representative from [major vendor]. I mentioned their peculiar UI and the guy just didn't get it. He went on to tell me how a single programmer designed and developed the UI all by himself in about a month!!! He thought this was really impressive! I realized in horror, the UI we were seeing every day represented the limited mind of a single technology obsessed programmer who applied his sense of architecture and programming to the patient care routines of operating rooms all across the country. The electronic chart contained the same fields as old papers forms, but the forms took about 3 minutes to fill while the electronic version took 15 AND while that is somewhat acceptable for long cases [I'd say a doable waste of time, not "acceptable" -ed.], many cases are short, from 15 to 30 minutes and that with the new system the nurse had even less time to take care of the patient - their major responsibility.</blockquote> This is simply stunning. I might also add "frightening." The following comes from a person with interest in usability: <blockquote style="font-family: arial;">I am working at the [name redacted] University Hospital. I asked several [another major HIT vendor] reps about their screen design and why they do not implement better ones. They said there is not a business case to spend the money upfront to do a proper Information Architecture Plan.</blockquote> I other words, if this is true (and I believe it is from my own experiences with numerous vendors), an HIT company's profits override the issues of a mission hostile user experience and cognitive overload of clinicians. The "business case" means "their profit." Looked at another way, physicians and other clinicians' cognitive energies serve as a bank for HIT vendor deficiencies and unwillingness to develop an appropriate and acceptable user experience. How many patients and clinicians subject to these devices know about these issues? I am going to go out on a limb here, similar to 1998 when I became one of the first (to my knowledge) to publicly stick my neck out with what at that time was a controversial website on HIT failures. Its title was "Medical Informatics and leadership of clinical computing", now <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/medinfo.htm" target="blank">here </a> under a new title. I had hoped that the HIT field's problems would diminish with the passage of time and with very direct exposure that all was not well. Instead, it appears the HIT industry and products have gotten worse. The existence of lists of a thousand+ HIT defects in major healthcare organizations, some resulting in clinician complaints about patient endangerment, and unshareable due to contractual gag clauses common in this industry, is simply intolerable. I am told many of these defects will likely never be fixed. I have only scratched the surface in reporting on these issues, being forced to do generic screen sketches, at my <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-testers-and_26.html" target="blank">series here </a>. There is no spin, no excuse, no dialog that can forgive such a situation. One must ask how products with thousands of defects could get into production. The existence of such lists is prima facie evidence that this industry is itself defective and that these devices are experimental - with clinicians and patients as unconsenting participants. Further, the shielding of the industry from liability on the "learned intermediary" basis is prima facie evidence of misuse of such laws. Even "learned clinicians" are being cognitively taxed and overloaded by these devices; they do not have unlimited cognitive capacity to deal with these defects. I believe this scenario is likely far worse than any practice I saw in pharma. It is becoming more clear to me and a number of my like minded colleagues that, as in pharma and the other medical device industries: <ul><li>A congressional investigation of the HIT industry's development, marketing, talent management, contracting, QC, and information sharing practices (on bugs, UI problems and other defects) is warranted; </li></ul><ul><li>These defect lists need to be public record so the public can evaluate whether their consent to be subjects of these devices is warranted;</li></ul><ul><li>Vendors should not be immune to liability for defects caused by cavalier IT development, testing and talent management practices; the article "Failure to Provide Clinicians Useful IT Systems: Opportunities to Leapfrog Current Technologies", Methods Inf Med 2008; 47: 4–7, by Ball et al. (PDF <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/Why%20HIT%20has%20failed_Ball_2008.pdf">here</a>) spells out some of these issues;</li></ul><ul><li>A societal process needs to be set up in parallel to those other two biomedical industries, pharma and [physical] medical devices, of staged clinical trials, validation, and regulation of HIT [virtual] devices by impartial bodies with appropriate, unconflicted expertise on board. "Finding a Cure: The Case for Regulation And Oversight of Electronic Health Records Systems", Harvard Journal of Law & Technology 2008 vol. 22, No. 1, by Hoffman and Podgurski (PDF <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/regulation_and_oversight_hoffman.pdf">here</a>) presents a case for oversight;</li></ul><ul><li>The evaluation needs to go far beyond the CCHIT features and functionality check, an almost useless evaluation criteria in my mind, directly to usability and effectiveness. For a good summary of CCHIT's deficits see p. 132-134 (p. 30-32 of the <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/regulation_and_oversight_hoffman.pdf">PDF</a>) in the Harvard Journal of Law & Technology article above. The major problem in HIT seems not absence of features, but a mission hostile user experience.</li></ul> From the latter Harvard Journal of Law & Technology article: <blockquote face="arial">The benefits of EHR systems will outweigh their risks only if these systems are developed and maintained with rigorous adherence to the best software engineering and medical informatics practices and if the various EHR systems can easily share information with each other. Regulatory intervention is needed to ensure that these goals are achieved. Once EHR systems are fully implemented, they become essential to proper patient care, and their failure is likely to endanger patient welfare.</blockquote> Indeed. Mine may sound like a radical position, but it is not. The existence of such secretive lists and lack of transparency is a highly significant problem. There is no other industry I know of that can push devices with hundreds or thousands of defects, some safety critical and others enhancing risk, onto the public, while preventing dissemination of defect lists. Imagine an aircraft industry where planes in the sky or air control devices have thousands of defects, some potentially leading to collisions or crashes. Pharma is being pushed to release negative trials results, for example. These issues need to be addressed in Washington before we dump $20 billion+ into a defective industry, instead of providing those funds for needed patient care of the poor and uninsured. -- SS

A Call For Congressional Investigation Of The HIT Industry - Is This Industry Trying to Harm Patients? Part 5 of a Series

( Note: Part 1 of this series is here , part 2 is here , part 3 is here , part 4 is here , part 5 is here , part 6 is here , part 7 ...

Đọc thêm »

Blogger connects to Google Friend Connect

When we introduced <a href="http://googleblog.blogspot.com/2008/09/follow-your-favorite-blogs.html">the Following feature for Blogger</a> last fall, we wanted to help you connect with fans of your own blog and discover communities of people who share your interests. It has been exciting to see Following grow over the past few months, to say the least. With nearly three million communities of followers on Blogger blogs, and with one person following a blog every second, we've been looking for ways to help these communities continue to thrive. As a first step toward that goal, today we are integrating the Blogger Following feature with <a href="http://www.google.com/friendconnect">Google Friend Connect</a>. Not only does this make it easier for anyone to follow a Blogger blog, but also it gives your blog expanded visibility across the web as your followers join other sites and share their activities with their friends. Blogger joins an open network of websites already using Friend Connect and visitors can now follow any Blogger blog by signing in with their Google, Yahoo, AOL, or OpenID credentials. The blogs that readers start to follow will appear alongside the other Friend Connect sites they've already joined. Additionally, you can find some new blogs and websites to join by checking out the profiles of other followers. This video shows you how to follow a blog: <object height="344" width="425"><param name="movie" value="http://www.youtube.com/v/s60ZgFnCTNs&hl=en&fs=1"><param name="allowFullScreen" value="true"><param name="allowscriptaccess" value="always"><embed src="http://www.youtube.com/v/s60ZgFnCTNs&hl=en&fs=1" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" height="344" width="425"></embed></object> If you have a Blogger blog and you're already using the Followers gadget, you don't need to do anything to get these new features up and running — we've already migrated all of the existing Followers gadgets to the new version with Friend Connect. To learn more, visit our blog post on <a href="http://buzz.blogger.com/2009/02/friendconnect-grow-your-blogs-community.html">Blogger Buzz</a>. Posted by Mendel Chuang, Product Marketing Manager, Google Friend Connect

Blogger connects to Google Friend Connect

When we introduced the Following feature for Blogger last fall, we wanted to help you connect with fans of your own blog and discover commu...

Đọc thêm »

Are Health IT Designers, Testers and Purchasers Trying to Harm Patients? Part 4 of a Series

Are Health IT Designers, Testers and Purchasers Trying to Harm Patients? Part 4 of a Series

( Note: Part 1 of this series is here , part 2 is here , part 3 is here , part 4 is here , part 5 is here , part 6 is here , part 7 ...

Đọc thêm »

Translate between 41 languages with Google Translate

Google Translate recently added <a href="http://translate.google.com.tr/">Turkish</a>, <a href="http://translate.google.co.th/">Thai</a>, <a href="http://translate.google.hu/">Hungarian</a>, <a href="http://translate.google.ee/">Estonian</a>, <a href="http://translate.google.com/?hl=sq">Albanian</a>, <a href="http://translate.google.com.mt/">Maltese</a>, and <a href="http://translate.google.com/?hl=gl">Galician</a> to the mix. The rollout of these seven additional languages marks a new milestone: automatic translations between 41 languages (1,640 language pairs!). This means we can now translate between languages read by <a href="http://googleblog.blogspot.com/2008/07/hitting-40-languages.html">98% of Internet users</a>. In just a few years, the machine translation group within <a href="http://research.google.com/">Google Research</a> has taken its initial research system from two languages to 41 languages and is now handling millions of translation requests a day. For several languages, Google Translate is the first freely available machine translation system for these languages. Of course, there's always room for improvement, and we're working hard to improve translation quality. Our statistical models are built from vast quantities of monolingual and translated texts using automated machine learning techniques. It's exciting and satisfying to work on a product that can help people access content they may otherwise be unable to understand. We've heard stories of people using Google Translate to help them do business internationally, and we've seen many websites (e.g., New York's <a href="http://www.mta.info/">Metro Transit Authority</a>) and blogs add the <a href="http://translate.google.com/translate_tools?hl=en&sl=ur&tl=fr">Google Translate My Page Gadget</a> to their pages to make their content more accessible to people from all over the world. Whenever I personally travel, I do lots of research on the web to figure out what to see and do, and where to stay and eat. With Translate, I'm able to use the <a href="http://translate.google.com/translate_s?hl=en">cross-language search</a> feature to find and access the latest info (e.g., restaurant recommendations, most recent trains/bus schedules, special events, etc.), which is often only available in the local language. More importantly, Translate provides people who may not otherwise have a lot of web content available in their own language with access to the wealth of content on the truly worldwide web. Posted by Jeff Chin, Product Manager

Translate between 41 languages with Google Translate

Google Translate recently added Turkish , Thai , Hungarian , Estonian , Albanian , Maltese , and Galician to the mix. The rollout of these ...

Đọc thêm »

Three Troubled Device Companies: ArthroCare, Stryker, AM2PAT

It was quite a week in the medical device business. Arthrocare Last week we discussed the shenanigans at <a href="http://www.arthrocare.com/">ArthroCare</a> Corporation <a href="http://hcrenewal.blogspot.com/2009/02/another-troubled-device-company.html">here</a>. Since then, more information has come out about in the Austin Business Journal <a href="http://www.bizjournals.com/austin/stories/2009/02/16/daily26.html">provided more information </a>about these improper practices: <blockquote> While the internal review, being conducted with the assistance of outside counsel Latham & Watkins LLP, is not yet complete, the ArthroCare’s audit committee has reviewed evidence that indicates that the company’s spine unit engaged in and may have caused others to engage in improper practices in certain instances by: * seeking separate reimbursement from insurers for company products in connection with procedures which were contractually reimbursed on a global basis; * making inaccurate statements in claims submitted to insurers regarding the place where particular procedures were performed; * providing physicians and insurers with descriptions of company technologies which had the effect of circumventing payor policies that did not cover such technologies; * recommending and advocating to physicians the use of a Current Procedural Terminology code to identify its coblation nucleoplasty technology that was not approved by the American Medical Association and may have not properly described the procedure that was performed. These improper practices identified so far may have occurred since at least 2006. Investigators were informed that certain sales and marketing personnel within the spine unit provided physicians and their billing staff with merchandise and administrative services at no charge potentially in exchange for their utilization of the company’s products. The audit committee has determined that company personnel at all levels lacked adequate health care compliance training and that company billing personnel lacked adequate training and supervision in insurance reimbursement requirements. In addition to considering and implementing remediation efforts, the committee is undertaking a review of such practices in other business units. </blockquote> Stryker Meanwhile, the New York Times <a href="http://www.nytimes.com/2009/02/20/business/20bone.html">reported</a> about <a href="http://www.stryker.com/en-us/index.htm">Stryker</a>: <blockquote> A Justice Department inquiry into Stryker’s marketing of human bone growth products has resulted in guilty pleas by former company sales representatives. One former sales official pleaded guilty two weeks ago, and another one did in November, court documents show. Stryker, a leading maker of medical devices, and the United States attorney’s office in Boston, which is conducting the inquiry, declined to comment. A spokeswoman for the attorney’s office said the investigation was continuing. The inquiry, which began last year, involves several issues, according to court papers and Stryker filings with the Securities and Exchange Commission. The questions include whether Stryker abused a federal exemption that authorized it to sell only limited quantities of its bone growth products for 'humanitarian' reasons, according to the documents. The two former sales officials pleaded guilty to charges that they had promoted off-label use of the products even though they knew that such use had earlier caused problems in some patients. The products in question are used by surgeons to aid the growth of bones that fail to heal properly. </blockquote> This case is not the only one raising ethical questions about Stryker's management. <blockquote> The inquiry poses new complications for Stryker, which is already operating under federal oversight as a result of an earlier Justice Department investigation of kickbacks paid by makers of artificial hips and knees to doctors. </blockquote> We posted about this previous issue, first <a href="http://hcrenewal.blogspot.com/2007/10/stryker-biomet-depuy-orthopedics-zimmer.html">here</a>, most recently <a href="http://hcrenewal.blogspot.com/2008/06/more-multi-million-dollar-orthopods.html">here</a>. AM2PAT Last, but most assuredly not least, was a story, (<a href="http://www.newsday.com/services/newspaper/printedition/wednesday/health/ny-hssyri256048602feb25,0,1308141.story">here</a> reported by Newsday) about AM2PAT: <blockquote> Federal authorities are hunting the mastermind behind a 'horrific case' in which bacteria-laden syringes shipped from an Angier, N.C., plant sickened hundreds of people and killed five. Two men pleaded guilty Monday in U.S. District Court in Raleigh for their roles in ignoring sterility standards at the former AM2PAT Inc. plant. The court heard of conditions at the plant more consistent with a Third World textile factory than a pharmaceutical facility. The men - plant manager Aniruddha Patel and quality control director Ravindra Kumar Sharma - were each sentenced to 4 1/2 years in prison for fraud and allowing tainted drugs into the marketplace. They were rewarded with a relatively light sentence in exchange for information about chief executive Dushyant Patel, whose company sold $6.9 million worth of heparin and saline syringes in 2006-07 that did not undergo proper sterility testing. Dushyant Patel, indicted late last week on 10 charges that include fraud and selling adulterated medical devices, has not been arrested. Authorities think he may have fled to his homeland in India and are seeking help from Interpol. Syringes from AM2PAT were pulled from the market early last year, and the Angier plant shuttered after an outbreak of Serratia, a bacterial infection, hit patients in Colorado, Texas, Illinois, Florida and other states. On Monday, prosecutors laid out a scheme before Judge Terrence Boyle in which the plant's operators routinely failed to follow sterility rules to keep production running faster. The drugs were not produced at the plant, but were loaded into syringes there, then shipped. The plant was subject to U.S. Food and Drug Administration requirements for its production. The syringes were supposed to be loaded in a 'clean room,' with employees in caps and gowns and air carefully ventilated to keep germs from spreading. A photograph entered into evidence Monday shows a 'clean room' refreshed with a common window fan held together with duct tape. In another photo, women work on an assembly line under lamps, surrounded by what look like green plastic recycling bins. Once the syringes were loaded with drugs, each batch was required to be held for two weeks, while employees tested for bacteria and other contaminants. If bacteria were cultured from the medicines, the whole batch should have been held back. That wasn't happening, court documents show. Batches of syringes went straight from the production line into the marketplace, with Sharma falsifying manufacturing dates to make it appear to regulators that requisite quality tests had been done. And when tests were done, results were ignored. </blockquote> Note first that none of these cases was isolated, in that each of these companies had questions raised about management behavior before (at Arthrocare, about accounting; at Stryker, about marketing and payments to doctors; at AM2PAT, raised by health care professionals about quality of its products.) In the US, we are undergoing yet another great debate about health care reform. Two big issues are the high cost and questionable quality of our health care. All three of these cases involved behavior that could have raised costs. Two may have had indirect effects on quality. One may have directly caused patient death and disease. Yet, even after executive arrogance, misbehavior, self-interest, and corruption have lead to the global financial meltdown, we are still not really addressing such behavior as a cause of our global health care crisis.

Three Troubled Device Companies: ArthroCare, Stryker, AM2PAT

It was quite a week in the medical device business. Arthrocare Last week we discussed the shenanigans at ArthroCare Corporation here . Sinc...

Đọc thêm »

NextGen and Vendor/Doctor Dialog: Yet Another Patronizing EHR Company of Certified HIT Experts?

<blockquote style="font-family:arial;">Note 6/9/09: To those reading this post via a link in an email from CCHIT's Mark Leavitt, see this June 7th post "<a href="http://hcrenewal.blogspot.com/2009/06/open-letter-to-mark-leavitt-chairman.html">Open Letter to Mark Leavitt</a>" first. The link you are at now is several months old, one of many posts I've written over the years about the scarcity of leadership-level Medical Informatics-trained professionals in the health IT vendor world. I consider that issue contributory to EHR's often mission hostile user experience (my series on that topic is <a href="http://tinyurl.com/b28s74">here</a>), and ultimately deleterious to patient well-being. I also believe the HIT industry has put its own interests ahead of that of patients in its inattention to HIT safety and <a href="http://jama.ama-assn.org/cgi/content/extract/301/12/1276">rejection of accountability</a>. Additional views on the recent CCHIT NJ Bill are at ePatients.net at "<a href="http://e-patients.net/archives/2009/05/david-kibbe-mark-leavitt-openness-vs-opacity.html">David Kibbe & Mark Leavitt:Openness vs. Opacity</a>" and "<a href="http://e-patients.net/archives/2009/06/dossia-microsoft-healthvault-google-healthillegal-in-nj.html">Dossia, Microsoft HealthVault & Google Health: Illegal in NJ?</a>". There are some now-familiar themes regarding CCHIT civility in those posts. 6/10: As a result of a link sent by a commenter, I am adding the post "<a href="http://www.hcplive.com/mdnglive/The_HIT_Realist/Kibbe_Leavitt">The Kibbe/Leavitt Rumble in the High Tech Jungle!</a>" to the list of interesting views in the note above. -- SS</blockquote> My early medical mentor, cardiothoracic surgery pioneer <a href="http://mmp.cjp.com/pipermail/openheart-l/2005-June/002000.html" style="font-family: arial;">Victor P. Satinsky, MD</a>, believed in public embarrassment (a.k.a. "sunlight") as a tool to fight bureaucracy and discrimination. I quote him on that. He wanted his NSF summer science training progam (SSTP) 10th grade students at Hahnemann Hospital to actually picket a clothing distributor, for example, when that distributor did not deliver our white coats nor a refund in a timely manner. He also was highly politically incorrect, for example having gay activists speak to our group of 200 high school students about bias and discrimination, at a time in the early 1970's when such talks were frowned upon. He took grief for that. Yet fairness and "critical thinking always, or your patient's dead" were his mantras. Dr. Satinsky must be rolling in his grave at what has become of medicine due to the type of bureaucracy we cover here at Healthcare Renewal. He would probably be a healthcare blogger himself were he still alive. At "<a href="http://hcrenewal.blogspot.com/2009/02/vendordoctor-dialog-on-healthcare-it.html" style="font-family: arial;">A Vendor/Doctor Dialog On Healthcare IT?</a>" I wrote that <blockquote>In response to my recent post to the American Medical Informatics Association's clinical information systems (CIS-WG) and organizational issues (POI-WG) workgroups about my <a href="http://hcrenewal.blogspot.com/2009/02/medinformaticsmd-in-wall-street-journal.html">WSJ letter to the editor</a>, Charles Jarvis, an AVP of Healthcare Industry and Government Relations at HIT vendor Nextgen.com thoughtfully suggested I "come and listen to how the government, providers, insurers and yes- HIT providers- can work together for the common good before drawing such strong conclusions." (Soothing blue font original - ed.) Dialog is a useful idea. I am always open to listening. However, dialog must be among equals in an atmosphere of complete transparency. Otherwise it is not dialog, it is politics. How can there be "dialog" in an environment where one side is able to squelch open discussion of the issues? ... p.s. in late 2003 after the <a href="http://www.businessweek.com/technology/content/nov2003/tc20031113_9818_tc119.htm">collapse of Merck's pipeline</a>, I wrote to your [NextGen's - ed.] CEO and HR department in Horsham about my availability to help in their EHR efforts. This was prior to the bulk of my writings on HIT difficulties. I did not so much as even get a response or inquiry, although I live thirty minutes away. Perhaps you could explore why your company showed no interest in perhaps the only formally trained medical informaticist in this area, and former CMIO of a major hospital in the region (Christiana Care).</blockquote> More on this below. I found Mr. Jarvis' patronizing "why don't you come and listen" line, sent in a nice soothing blue font, disturbing, since it's vendors (immune from liability and from intra-organization scrutiny even when events such as <a href="http://hcrenewal.blogspot.com/2009/02/healthcare-it-blamed-in-patient-death.html" style="font-family: arial;">this</a> and <a href="http://iig.umit.at/efmi/badinformatics.htm" style="font-family: arial;">these</a> occur), not physicians and physician informaticists, who need to do the listening. However, something else was at the back of my mind, and information saver that I am (I did run Merck Research Lab's science library and historical science archives department, after all), I checked my disk backups. What I found reflects something I've noted numerous times in the past. Interactions with HIT vendors - both their products and their people - have most often been quite annoying. Here is Mr. Jarvis' <a href="http://web.archive.org/web/20100103141103/http://nextgen.com/about-nextgen/leadership-structure.html#15" style="font-family: arial;">bio</a>: [Nov. 2011 editor's note - the bio disappeared from the original link; the link now points to archive.org] <blockquote face="arial"><h5>Charles Jarvis, Assistant Vice President, Healthcare Industry Services & Government Relations</h5> Charles W. Jarvis FACHE is Assistant Vice President for Healthcare Industry Services and Legislative Affairs – having been in this role since January 2005 [this date becomes relevant as below - ed.] Mr. Jarvis' responsibilities include community and partnership business development including overseeing the company grants and funding procurement program, government relations, new business planning, and educational efforts. Mr. Jarvis is active in the Electronic Health Record Vendor Association (EHRVA), currently holding the position of Chairman of the Government Affairs and Affiliated Organizations Workgroup.Prior to joining NextGen, Mr. Jarvis was in hospital and physician group practice management for 25 years in both the New Jersey and Massachusetts markets. Mr. Jarvis holds a Masters Degree in Business with a concentration in Health Administration [i.e., he took a few courses in health admin - ed.] from Temple University and a Bachelors Degree in Economics from the Wharton School of the University of Pennsylvania. [Common to the HIT industry and to observations on HC Renewal about HC leadership in general, I note no clinical experience or credentials - ed.] He is also a Fellow in the American College of Health Care Executives and holds the American Medical Informatics Certification for Health Information Technology [what is that? More below - ed.] </blockquote> Now, it was bad enough my earlier inquiries to the NextGen CEO were ignored. Far worse is the outcome of my application to NextGen for a position as Director of Industry Relations in late 2004: <blockquote>NextGen Healthcare is currently looking for an individual to manage our Industry Relationships. We are a rapidly growing, publicly held company looking for an aggressive, self-motivated individual who is seeking a challenging position with a top tier healthcare IT company. As the Director of Industry Relations, you will be responsible for managing industry relations. This will include relationship management with the consultant marketplace, medical societies, health plans, and our Value Added Resellers. Qualified candidates will have preferably healthcare IT background either as a project manager, consultant, marketing manager, or sales representative . Applicant must also be career oriented, professional, and organized, possess excellent oral and written communication skills and be detail oriented. Working knowledge of MS Excel, Word and PowerPoint a must. Local and national travel required.</blockquote> Here is the relevant email thread: <blockquote style="font-family: arial;">From NextGen: In a message dated 12/27/2004 9:04:43 A.M. Eastern Standard Time, JWong@nextgen.com writes: Hello Dr. Silverstein, We would like to schedule an interview for you the week of January 3, 2005. Would you please advise your schedule? I will be arranging an meeting with the president and one of our vice presidents. Please let me know what day and time are best. Thank you. Jennifer Wong Business Development Coordinator > NextGen Healthcare Information Systems, Inc. 795 Horsham Road Horsham, PA 19044 215.657.7010 (p) 215.657.7011 (f) jwong@nextgen.com Website - www.nextgen.com My reply back: From: ScotSilv@aol.com [mailto:ScotSilv@aol.com] Sent: Thursday, January 06, 2005 12:44 PM To: JWong@nextgen.com Subject: Re: Interview Hi Jennifer, I have been away for the New Year. I'm following up on getting an interview schedule set. I also left a voicemail. Regards, Scot NextGen gets back to me: In a message dated 1/10/2005 11:47:51 A.M. Eastern Standard Time, JWong@nextgen.com writes: Hi Dr. Silverstein, I have forwarded your resume internally to the appropriate persons. Thank you - you should be hearing from someone shortly. Thank you. Jennifer Wong Business Development Coordinator NextGen Healthcare Information Systems, Inc. 795 Horsham Road Horsham, PA 19044 215.657.7010 (p) 215.657.7011 (f) jwong@nextgen.com Website - www.nextgen.com My response after waiting, and waiting: From: ScotSilv@aol.com [mailto:ScotSilv@aol.com] Sent: Thursday, January 20, 2005 To: JWong@nextgen.com Subject: Re: Interview Dear Jennifer, I still await contact from NextGen. Please advise if this opportunity is still available. I am in conversation with other organizations and want to finalize my schedules. Sincerely, Scot </blockquote> Then ... silence. I never heard from the company again. (Dialog? What dialog? There does not appear to have been even fundamental respect.) In summary, an AVP who may very well have -- hypothetically speaking; I'd never heard of him before he responded to my recent workgroup posts -- made a decision about blowing me off as a Director in 2005 (he started in Jan. 2005) now tells me how I should "come and listen to how the government, providers, insurers and yes- HIT providers- can work together for the common good before drawing such strong conclusions." I can also add that NextGen did indeed hire a medical informaticist straight away from the same program I trained in, <a href="http://ycmi.med.yale.edu/research/rgraduates.html">Yale'</a>s, sometime after that person's completion of a postdoctoral fellowship in July 2006, as a "physician consultant." I had finished the fellowship in 1994 after a number of years of medical practice and by 2005 had quite a lot of <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/cases/?loc=about">applied and management experience</a> under my belt. (My current bio does not include my time as Medical Programs Manager for quasi-governmental agency <a href="http://www.septa.com/">SEPTA</a>, with much interaction with SEPTA Industrial Relations, and with federal regulators <a href="http://www.dot.gov/">DOT</a>, <a href="http://www.fra.dot.gov/">FRA</a>, <a href="http://www.nida.nih.gov/">NIDA</a> and others on health matters in the transportation industry, but it did then.) So, I was entirely blown off without so much as an explanation in 2005, but a new informatics trainee hired in 2006. This raises a number of questions. Hypothetically speaking, was this due to: <ul style="font-family: arial;"><li>Lack of recognition of my background, which included extensive clinical, medical informatics and EHR experience and working in a critical role in a quasi-governmental organization with links to several federal agencies?</li><li>Age discrimination? I was in my late 40's at the time.</li><li>Perhaps it was felt I had <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/cases/?loc=cases&sloc=leadership">too much experience for the organization</a>? </li><li>Hiring the young and relatively inexperienced on the basis of "cheap?"</li><li>My patient-centric advocacy views on HIT, as in, "the patient must be protected from defective HIT?"</li></ul> I am not making accusations in any way, only raising questions. Only the company knows the answers, of course, and it is their right to hire someone or not hire them or even have them in for interview. Even basic courtesy of followup with the professional community is optional. However, I rest my case regarding the really annoying nature of health IT vendors beyond just their often <a href="http://hcrenewal.blogspot.com/2009/02/are-health-it-designers-idiots-part-1.html" style="font-family: arial;">poorly conceived products</a>, and their inability or unwillingness to tap experienced healthcare informatics professionals as I've written about before on HC Renewal. Finally, what is the "American Medical Informatics Certification for Health Information Technology?" claimed in Mr. Jarvis' biography? I have never heard of it before and a <a href="http://www.google.com/search?client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&channel=s&hl=en&q=American+Medical+Informatics+Certification+for+Health+Information+Technology&btnG=Google+Search" style="font-family: arial;">Google search</a> seems unrevealing. Could it be an overstated credential to impress stockholders and investors? (We in informatics strive for semantic clarity). AMIA does not "certify" anyone in informatics to my knowledge although they offer a short course in the <a href="http://www.amia.org/10x10" style="font-family: arial;">10x10</a> program that awards a "<a href="http://www.amia.org/10x10/students.asp" style="font-family: arial;">Certificate of Completion</a> in the 10x10 Program." I'm not aware of an American certification board in HIT. Is it like another <a href="http://hcrenewal.blogspot.com/2008/05/htrea-parallel-world-of-hit.html" style="font-family: arial;">Htraesian</a> informatics "certification", CPHIMS, as I described <a href="http://hcrenewal.blogspot.com/2008/04/is-himss-certified-professional-in.html" style="font-family: arial;">here</a>? Is it a certificate like <a href="http://www.drexel.com/online-degrees/information-sciences-degrees/cert-hci/index.aspx" style="font-family: arial;">this</a>, which students get after completing the intensive 3-course graduate program in an accredited university that I created? Perhaps something you get after completing one of <a href="http://www.nlm.nih.gov/ep/GrantTrainInstitute.html" style="font-family: arial;">these</a> programs, created and funded by Don Lindberg and other informatics pioneers, that I spent two years of my life in? Or perhaps it's more like <a href="http://www.healthitcertification.com/" style="font-family: arial;">this</a> three day 10 course miracle certification and button? "<a href="http://www.healthitcertification.com/regonsite.html" style="font-family: arial;">Consists of 10 course, two and a half days curriculum and CPEHR Certification Examination</a>" [is that like a 10 course meal? - ed.] Oh, I forgot. In healthcare informatics, <a href="http://hcrenewal.blogspot.com/2009/02/informatics-or-infomagic-health-it.html" style="font-family: arial;">everyone's an expert</a>. Finally, I guess I won't be applying to <a href="http://www.nextgen.com/" style="font-family: arial;">NextGen</a> again. They might blow me off. Again. -- SS

NextGen and Vendor/Doctor Dialog: Yet Another Patronizing EHR Company of Certified HIT Experts?

Note 6/9/09: To those reading this post via a link in an email from CCHIT's Mark Leavitt, see this June 7th post " Open Letter to M...

Đọc thêm »

Google Toolbar 6 beta for Internet Explorer: back to basics

The Toolbar Team has always been focused on improving your web experience. We started with the goal of making search more accessible, and a couple of iterations led to improvements like search suggestions, Google Bookmarks, Autofill, and Custom Buttons and gadgets. Now we're bringing the focus back to our core areas of search and navigation. First of all, in today's Toolbar 6 launch for Internet Explorer we're introducing the <a href="http://www.google.com/support/toolbar/bin/answer.py?answer=81305">Quick Search Box</a> (QSB) feature that provides search functionality outside of the browser. Just click on the Google logo in the taskbar to trigger it (or use the Ctrl+Space shortcut for quicker access). As you type, it will provide search and website suggestions, relevant bookmarks, and even allow you to launch applications directly from the search box. Try typing "solitaire" to see the application launcher in action. And here's the best part: as you use the QSB, it'll customize itself to your usage pattern, so over time you have to type fewer characters to navigate to your favorite sites and applications. <a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhK2gGDBbMJb-niVkJuaMaJJrESRK90rmGpgiUTO3BeG-OLawI7m9-llg5afkiQbNwzZTY8AMJLwKLjCNTEYGm5bZTWHv18D6g_TEl2YXSs_MJPyzNdWdqb3kYKiGg6EFM046z3GPnIwfug/s1600-h/Picture+1.png" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"><img alt="" border="0" id="BLOGGER_PHOTO_ID_5306512005593767906" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhK2gGDBbMJb-niVkJuaMaJJrESRK90rmGpgiUTO3BeG-OLawI7m9-llg5afkiQbNwzZTY8AMJLwKLjCNTEYGm5bZTWHv18D6g_TEl2YXSs_MJPyzNdWdqb3kYKiGg6EFM046z3GPnIwfug/s400/Picture+1.png" style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 368px; height: 242px;" /></a> In addition, we're building on our existing suggest functionality in the Toolbar search box by bringing elements from our search results page directly into the toolbar. We're experimenting with displaying high-quality website suggestions and sponsored links as you type your query. Clicking on these will take you directly to the website (try typing "cnn" in the toolbar to see an example). Going forward, we'll continue to explore new ideas and optimize the search box to give you the best experience possible. Lastly, we wanted to bring the <a href="http://www.google.com/support/toolbar/bin/answer.py?hl=en&answer=115561">new tab page</a> to our Internet Explorer users (our Firefox Toolbar users have been enjoying it already <a href="http://googleblog.blogspot.com/2009/01/google-toolbar-in-firefox-personalized.html">for the last few weeks</a>). You can quickly access your most viewed sites, recently closed tabs and bookmarked pages — all from this new tab page. Editing your most visited sites is easy, and all this data remains locally in your browser, meaning none of your most viewed sites or recently closed pages are sent back to Google. Those who prefer new tabs to open a blank page or a website can do so in the Internet Explorer or Toolbar settings menus. So, <a href="http://toolbar.google.com/T6/intl/en/?tbbrand=GZEZ&utm_campaign=en&utm_source=en-et-gblog&utm_medium=et">give the latest toolbar a shot</a> — it's available in 40 languages — and don't forget to <a href="http://www.google.com/support/toolbar/bin/request.py?contact_type=problem">let us know what you think</a>. Update on 3/24: Google Toolbar 6 is now <a href="http://toolbar.google.com/T6/intl/en/?tbbrand=GZEZ&utm_campaign=en&utm_source=en-et-gblog&utm_medium=et&rd=f" target="_blank">out of beta</a>. Posted by Zelidrag Hornung, Engineering Lead, Toolbar Team

Google Toolbar 6 beta for Internet Explorer: back to basics

The Toolbar Team has always been focused on improving your web experience. We started with the goal of making search more accessible, and a ...

Đọc thêm »